Navigation Links
Detecting anomalies in heart rythm

Researchers in Germany have developed a new risk assessment methodology to detect any anomaly in heart beat rythm and patient's risk of cardiac death.

ECG is the basic data with which patient's risk of cardiac death can be determined and analysed by the computer.The time interval between successive heartbeats is the first variable to be calculated.// When the programme has completed its analysis, it outputs atleast three characteristic values describing the heart rythm to cardiologists.

Regular checkups and ECG tests help doctors to decide whether patients require treatment with drugs to combat arrhythmia or may be implant a defibrillator, a device similar to a pacemaker, which operates only when the heartbeat starts to get out of step.

Mathematicians at the new Fraunhofer Institute ITWM together with a private service company, developed a new method called alphacardio in order to overcome the problems experienced with the test. Many of the programmes in use today only look at the linear relationship between data.

The approach is to use model of non-linear dynamics, which describe heart rhythm- as an open complex system. This gives a better chance of detecting temporal changes in heartbeat rhythm and placing them in the context of the individual patients' health.

The reliability of its prediction has been tested in collaboration with practising physicians at the major hospital in Ludwigshafen. Comparisons were made with an earlier study of ECG data on 600 patients who had suffered a heart attaack, and the predicted risk was compared with the fate of these patients. According to physicians the results are very promising and effective.


'"/>




Page: 1

Related medicine news :

1. Detecting brain aneurysms
2. Detecting Colorectal Cancer
3. Photographs An Effective Tool In Detecting Skin Cancer
4. Mammograms The Best In Detecting Breast Cancer
5. Detecting Lung Cancer Early
6. Detecting Lung Cancer In Its Initial Stages
7. A New Way Of Detecting Osteoporosis
8. Detecting DNA Damage With In-Vivo Alkaline Comet Assay
9. CT Pulmonary Angiography Scan More Effective In Detecting Dangerous Blood Clots In The Legs
10. Researchers Develop Device For Detecting Atherosclerotic Plaques
11. India Needs To Pay More Attention To Detecting Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: